The Foot & Ankle Consolidation Trend Continues

May 19, 2022
1 min read

On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.

In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.

Recent Posts

See All

Geriatric Ankle Fractures: Fixation Affects Function

by Vince Vacketta, DPM Geriatric ankle fractures carry high morbidity. Fixation choice influences early weight-bearing, mobilization, complication risk, and functional recovery – all critical in frail

Achilles Sleeve Avulsion: Five-Year Outcomes

Does insertional reattachment surgery deliver durable pain relief, function, and return to sport at two and five years? In a retrospective cohort study , researchers reviewed 39 patients (mean age 45

Deltoid Ligament Augmentation Shows Promise as Alternative to Screw Fixation for Ankle Fractures

A randomized controlled trial investigated whether the deltoid ligament augmentation (DLA) could replace trans-syndesmotic screw fixation (TSSF). Study design and results The study enrolled 59 pati

Comments